NNVC: Gunggung utang perusahaan NanoViricides Corp

NanoViricides, Inc. (NNVC) attracts rare biochemists through stock options to develop nanomedicines. However, the risk of scientific failure compared to mRNA technologies remains the primary challenge, which confirms the debt load status displayed on GURU.Markets; here 0.00 determines this parameter level. Simultaneously, the business competes for early-stage investments while avoiding direct price competition.

NanoViricides Inc. - Utang perusahaan NNVC (periode 04.07.2022 - 28.10.2026)

Rincian analitis lan laporan data perusahaan NanoViricides, Inc. (NNVC)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega nanoviricides.com|NNVC - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar NanoViricides Corp|NNVC - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham NanoViricides|NNVC - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih nanoviricides.com|NNVC - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal NanoViricides, Inc.|NNVC - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal nanoviricides.com|NNVC - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NanoViricides Corp|NNVC - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak NanoViricides

Analisis fundamental perusahaan:NNVC NanoViricides Inc.

For long-term risk management, it is critical to track total credit obligations, which at the current value of 0.00 reflect the company's level of borrowed capital. By analyzing the overall state of obligations, an investor can see the liability dynamics of NanoViricides, Inc. (NNVC), allowing for an assessment of the nanocapsule developer's financial stability and its ability to fund scientific research without a critical debt load.

Pesaing wigati